Protocol AML-MM-2000 treatment results of unfavorable prognostic group in children with acute myeloid leukemia

Protocol AML-MM-2000 treatment results of unfavorable prognostic group in children with acute myeloid leukemia

Protocol AML-MM-2000 treatment results of unfavorable prognostic group in children with primary acute myeloid leukemia (AML) in Russia and Belarus are presented. 105 children at the age from 2 weeks till 18 years (a median age — 10.8 years) are included in the study. In 91 patients (86.7%) hematolog...

Full description

Saved in:

Bibliographic Details
Main Authors:	N. P. Kirsanova, O. V. Aleinikova, A. M. Kustanovich, T. V. Savitskay, R. I. Yutskevich, E. V. Volochnik, L. V. Baidun, Yu. E. Mareiko, Yu. S. Strongin, N. V. Minakovskay, N. V. Migal, I. V. Proleskovskay, I. V. Emelyanova, O. V. Karas, A. G. Drekov, M. M. Maschan, D. V. Litvinov, N. V. Myakova, E. V. Skorobogatova, D. D. Baidildina, I. I. Kalinina, G. G. Solopova, E. V. Suntsova, U. N. Petrova, L. A. Hachatryan, M. M. Scheider, A. A. Maschan
Format:	Article
Language:	Russian
Published:	ABV-press 2022-11-01
Series:	Онкогематология
Subjects:	children acute myeloid leukemia intermediate and unfavorable prognosis survival hematopoietic stem cells transplantation
Online Access:	https://oncohematology.abvpress.ru/ongm/article/view/645
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Clinical and genetic characteristics of acute myeloid leukemia with t(8;21) in children and results of therapy according to protocol AML-MM-2000
by: I. I. Kalinina, et al.
Published: (2014-07-01)

2-Clorodeoxyadenosine in therapy of children with Langerhans cell histiocytosis
by: G. G. Solopova, et al.
Published: (2022-11-01)

Efficiency of therapy for acute promyelocytic leukemia in children, by using all-trance retinoic acid, cytosine arabinoside, and smaller-dose anthracyclines
by: E. V. Samochatova, et al.
Published: (2022-11-01)

Infections caused by rare mold fungi in hematology
by: I. I. Kalinina, et al.
Published: (2014-07-01)

Results of candidemia treatment in children with hematologic malignancies: single center experience
by: I. I. Kalinina, et al.
Published: (2014-07-01)

Results of differential treatment of children with juvenile myelomonocytic leukemia with 13-cis retinoic acid and low dose cytosine-arabinoside
by: L. A. Khachatrian, et al.
Published: (2022-11-01)

SECONDARY SOLID TUMORS IN CHILDREN AFTER ALLOGENEIC HEMATOPOIETIC STEM CELLS TRANSPLANTATION: CASE REPORTS AND LITERATURE REVIEW
by: Yu. V. Skvortsova, et al.
Published: (2017-06-01)

Clinical and microbiological characteristics of bacteremia caused by Streptococcus viridans in children with hematologic malignancies
by: M. V. Panina, et al.
Published: (2015-01-01)

Molecular cytogenetics for acute megakaryocytic leukemia diagnosis
by: E. A. Matveeva, et al.
Published: (2014-07-01)

Late non-infectious lung damage in children after allogeneic hematopoietic stem cells transplantation
by: Yu. V. Skvortsova, et al.
Published: (2015-06-01)

Acute lymphoblastic leukemia in children
by: M. A. Maschan, et al.
Published: (2022-11-01)

HEMOPHAGOCYTIC SYNDROME IN EMERGENCY AND INTENSIVE PEDIATRICS
by: M.A. Maschan, et al.
Published: (2011-03-01)

LYMPHOID NEOPLASMS AFTER ALLOGENEIC HEMATOPOIETIC STEM CELLS TRANSPLANTATION. THE CASE OF SECONDARY HODGKIN’S LYMPHOMA, DIFFERENTIAL DIAGNOSIS WITH POST-TRANSPLANT LYMPHOPROLIFERATIVE DISEASE
by: Yu. V. Skvortsova, et al.
Published: (2017-06-01)

Use of plerixafor for hematopoietic stem cells mobilization in allograft donors
by: D. N. Balashov, et al.
Published: (2015-01-01)

Epidemic outbreak of candidemia caused by unusual types of Candida non-albicans: clinical course patterns and search for the source
by: I. I. Kalinina, et al.
Published: (2014-07-01)

Immediate side effects study of locally manufactured filgrastim («Leucostim®») in neutropenia treatment and prophylactics in children
by: N. Yu. Shipovskaya, et al.
Published: (2022-11-01)

Quantitative analysis of chimerism after allogeneic hematopoietic stem cell transplantation with molecular genetic methods
by: V. A. Lavrinenko, et al.
Published: (2014-09-01)

Analysis of incidence and prognostic significance <i>FLT3, c-KIT</i> and <i>NPM1</i> genes mutation in children with acute myeloid leukemia
by: L. V. Guk, et al.
Published: (2022-11-01)

Hematopoietic stem cell transplantation in juvenile myelomonocytic leukemia: analyse one centre experience and literature review
by: M. A. Maschan, et al.
Published: (2014-07-01)

Risk factors of cytomegalovirus infection in patients after allogeneic hematopoietic stem cells transplantation
by: D. N. Balashov, et al.
Published: (2022-11-01)

Clinical characteristics and prognostic significance of extramedullary involvement in childhood acute myeloid leukemia
by: A. K. Ignatova, et al.
Published: (2021-04-01)

Treatment of B-cells non-Hodgkin lymphomas with combined immunochemotherapy: ability to treatment optimization
by: N. V. Smirnova, et al.
Published: (2015-12-01)

Sexual development and gonads function in children and adolescents after allogeneic stem cell transplantation using different conditioning regimes
by: L. I. Papusha, et al.
Published: (2022-11-01)

CD-19-directed immunotherapy resistance mechanisms of B-precursor acute lymphoblastic leukemia
by: E. V. Glukhanyuk, et al.
Published: (2019-01-01)

Minimal residual disease prognostic value for relapse-free survival of children with acute lymphoblastic leukemia treating according to ALL-MB-2002 protocol (monofactorial and multifactirial analysis)
by: N. N. Savva, et al.
Published: (2022-11-01)

HETEROGENEITY OF CHILDHOOD B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA (EGIL SUBTYPE BIV)
by: I. A. Demina, et al.
Published: (2018-02-01)

Value of bioimpedance analysis and anthropometry for complication prediction in children with malignant and non-malignant diseases after hematopoietic stem cells transplantation
by: G. Ya. Tseytlin, et al.
Published: (2014-07-01)

Pharmacokinetics of low molecular weight heparins in thrombosis, complicate the treatment of children with cancer
by: V. V. Dmitriev, et al.
Published: (2021-04-01)

Lineage switch in relapse of acute leukemia with rearrangement of MLL gene (KMT2A). literature review and case reports
by: E. A. Zerkalenkova, et al.
Published: (2016-08-01)

Spontaneous remission of acute myeloid leukemia in children. Case series and literature review
by: V. V. Klyukhin, et al.
Published: (2024-12-01)

Venous thrombosis in children, adolescents and young adults with acute lymphoblastic leukemia receiving chemotherapy in the Republic of Belarus
by: V. V. Dmitriev, et al.
Published: (2019-07-01)

Hematopoietic stem cell transplantation in children with acute myeloid leukemia
by: Z. M. Dyshlevaya, et al.
Published: (2022-11-01)

Features of Development and Course of Disseminated Intravascular Coagulation Syndrome During Surgical Interventions in Children with Oncological Diseases
by: N. P. Leonov, et al.
Published: (2020-07-01)

Immunophenotypic features of bone marrow tumor cell in Burkitt lymphoma/leukemia: B-lineage acute lymphoblastic leukemia diagnostics opportunities
by: I. A. Demina, et al.
Published: (2017-04-01)

Detection of 11q23 (MLL) rearrangements in infant acute lymphoblastic leukemia
by: G. A. Tsaur, et al.
Published: (2014-07-01)

Combined chemoimmunotherapy of patients with mature B-cell non-Hodgkin lymphomas age group until 18 years: results of multicenter study NHL 2004 m with rituximab and modified B-NHL BFM 90 protocol applications
by: E. V. Samochatova, et al.
Published: (2022-11-01)

Guidelines of Russian Expert Council on diagnostic and therapy of patients with primary immunne thrombocytopenia
by: A. A. Maschan, et al.
Published: (2022-11-01)

Endothelial injury syndromes after hematopoietic stem cell transplantation: analyzing clinical case
by: Y. V. Skvortsova, et al.
Published: (2022-11-01)

Epstein–Barr virus infection in patients after hematopoietic stem cells transplantation
by: D. N. Balashov, et al.
Published: (2022-11-01)

Treatment of invasive pulmonary aspergillosis according to recommendations of Infectious Diseases Society of Americaриведена в соответствии со стандартной системой, используемой в руководствах IDSA.
by: G. A. Klyaksova, et al.
Published: (2022-11-01)